1. Home
  2. DUO vs ARTL Comparison

DUO vs ARTL Comparison

Compare DUO & ARTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DUO
  • ARTL
  • Stock Information
  • Founded
  • DUO 2011
  • ARTL 2011
  • Country
  • DUO China
  • ARTL United States
  • Employees
  • DUO N/A
  • ARTL N/A
  • Industry
  • DUO Real Estate
  • ARTL Biotechnology: Pharmaceutical Preparations
  • Sector
  • DUO Finance
  • ARTL Health Care
  • Exchange
  • DUO Nasdaq
  • ARTL Nasdaq
  • Market Cap
  • DUO 6.1M
  • ARTL 7.0M
  • IPO Year
  • DUO 2019
  • ARTL N/A
  • Fundamental
  • Price
  • DUO $3.24
  • ARTL $4.91
  • Analyst Decision
  • DUO
  • ARTL Buy
  • Analyst Count
  • DUO 0
  • ARTL 2
  • Target Price
  • DUO N/A
  • ARTL $30.00
  • AVG Volume (30 Days)
  • DUO 6.2M
  • ARTL 126.6K
  • Earning Date
  • DUO 08-29-2025
  • ARTL 11-11-2025
  • Dividend Yield
  • DUO N/A
  • ARTL N/A
  • EPS Growth
  • DUO N/A
  • ARTL N/A
  • EPS
  • DUO N/A
  • ARTL N/A
  • Revenue
  • DUO $56,189,313.00
  • ARTL N/A
  • Revenue This Year
  • DUO N/A
  • ARTL N/A
  • Revenue Next Year
  • DUO N/A
  • ARTL N/A
  • P/E Ratio
  • DUO N/A
  • ARTL N/A
  • Revenue Growth
  • DUO 48.30
  • ARTL N/A
  • 52 Week Low
  • DUO $1.24
  • ARTL $4.20
  • 52 Week High
  • DUO $74.72
  • ARTL $28.60
  • Technical
  • Relative Strength Index (RSI)
  • DUO 56.68
  • ARTL 30.55
  • Support Level
  • DUO $3.00
  • ARTL $4.60
  • Resistance Level
  • DUO $3.59
  • ARTL $5.53
  • Average True Range (ATR)
  • DUO 0.81
  • ARTL 0.53
  • MACD
  • DUO 0.04
  • ARTL -0.04
  • Stochastic Oscillator
  • DUO 45.60
  • ARTL 13.71

About DUO Fangdd Network Group Ltd.

Fangdd Network Group Ltd is an investment holding company. It is engaged in the provision of real estate information services through its online platform which also offers integrated marketing services for individual customers, real estate developers, and agents in China. Its SaaS-based solutions help real estate agents to connect with essential business resources, including customers, property listings, capital, and transaction data. The company generates the majority of its revenue from Base commission from transactions in China.

About ARTL Artelo Biosciences Inc.

Artelo Biosciences Inc is a United States-based development-stage biopharmaceutical company. It is engaged in the development of therapeutics that target lipid signaling pathways, including the endocannabinoid system, a family of receptors & neurotransmitters that form a biochemical communication network in the body. It is focused on discovering, licensing, developing, & commercializing treatments that control endocannabinoid systems. The company pursues technologies & programs that offer proprietary approaches to cannabinoid-based therapies, & those derived from the cannabis plant & synthetic cannabinoids, as well as new chemical entities & compounds. The firm's flagship program is designed to be a patent-protected cannabinoid drug combination treatment for a rare & orphan disease.

Share on Social Networks: